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Abstract
Background: Dengue disease severity is usually classified using criteria set up by the World
Health Organization (WHO). We aimed to assess the diagnostic accuracy of the WHO
classification system and modifications to this system, and evaluated their potential practical
usefulness.
Methods: Patients, admitted consecutively to the hospital with severe dengue, were classified
using the WHO classification system and modifications to this system. Treating physicians were
asked to classify patients immediately after discharge. We calculated the sensitivity of the various
classification systems for the detection of shock and the agreement between the various
classification systems and the treating physician's classification.
Results: Of 152 patients with confirmed dengue, sixty-six (43%) had evidence of circulatory failure.
The WHO classification system had a sensitivity of 86% (95%CI 76–94) for the detection of patients
with shock. All modifications to the WHO classification system had a higher sensitivity than the
WHO classification system (sensitivity ranging from 88% to 99%). The WHO classification system
was in only modest agreement with the intuitive classification by treating physicians whereas several
modified classification systems were in good agreement.
Conclusion: The use of the WHO classification system to classify dengue disease severity is to be
questioned, because it is not accurate in correctly classifying dengue disease severity and it lacks
sufficient agreement with clinical practice.
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Background
Dengue virus infections are recognized as major public
health problems in tropical and subtropical regions. Each
year an estimated 100 million infections occur and
between 250.000 and 500.000 severe cases are reported to
the World Health Organization (WHO) [1]. Infection
with any of the four dengue virus serotypes may give a
broad spectrum of clinical manifestations ranging from
no or minimal symptoms that cannot be easily distin-
guished clinically from other viral infections to a more
severe form of disease that is characterized by a haemor-
rhagic tendency and increased vascular permeability. The
WHO set up a classification system to differentiate
between the self-limiting though debilitating dengue fever
(DF), and the potentially lethal dengue haemorrhagic
fever (DHF) [2]. According to these criteria, DHF is
defined by the presence of fever, a haemorrhagic ten-
dency, thrombocytopenia and some evidence of plasma
leakage due to increased vascular permeability. DHF is
further subdivided, with most severe cases categorized as
dengue shock syndrome (DSS) when circulatory failure is
present [2].
A standardized classification system for the severity of
dengue virus infections is crucial for optimal communica-
tion of scientific data to improve our understanding of the
pathogenesis and treatment of the disease. Incorrect dis-
ease severity classification may lead to faulty decision
making in choosing the most appropriate treatment for
the individual patient. Although the WHO classification
system has been widely applied in research settings and
publications, its use in everyday clinical practice has not
proven easy or practical. In recent years, several studies
reported difficulties with classification, inconsistencies in
the WHO classification system and some found it neces-
sary to define new categories to identify severe cases that
do not meet the criteria for DHF or DSS [3-9].
These findings raise the question if the current WHO clas-
sification system is appropriate for the classification of
dengue disease severity. To answer this, we assessed the
diagnostic accuracy of the WHO classification system and
modifications to this system. The presence of shock was
used as marker of disease severity. By comparing the vari-
ous classification systems with an intuitive classification
done by treating physicians, we additionally evaluated the
practical usefulness of the WHO classification system and
the various modified classification systems.
Methods
Patients and clinical procedures
The study was conducted from February 2001 to April
2003 on the paediatric intensive care unit and paediatric
ward of the Dr. Kariadi Hospital in Semarang, Central
Java, a region in Indonesia where dengue is endemic.
Patients, aged 2 to 14 years, consecutively admitted to the
hospital with suspected severe dengue virus infection were
included, provided that a parent or legal guardian gave
informed consent. No strict criteria were used for inclu-
sion in the study. Treating physicians could use the WHO
case definition for dengue haemorrhagic fever as a guiding
principle. If patients did not meet all criteria but a clinical
suspicion of severe dengue virus infection was present,
these patients were still eligible for inclusion. Members of
the study team recorded demographic data, medical his-
tory, physical examination findings, clinical course and
routine laboratory test results for each patient on a stand-
ard data form. The tourniquet test was performed on
admission. Since it may be negative when circulatory fail-
ure is present the test was repeated after recovery from
shock. Platelet count was performed daily. Haematocrit
was measured at admission, every 2 hours for the first 6
hours and than every 6 hours until stable. Both haemat-
ocrit and platelet count were repeated in the event of clin-
ical deterioration (i.e. recurrent shock, massive
hemorrhage). Additional blood samples for diagnostic
procedures were obtained on day of admission and on
day 7 after enrolment. The ethics committee of the Dr.
Kariadi Hospital approved all clinical and laboratory
aspects of this study.
Classification of disease severity
The study was initially designed to study pathophysiolog-
ical mechanisms of hemorrhagic tendencies in patients
with a severe dengue virus infection. For this we collected
blood samples on several points in time during admission
for the analysis of coagulation activity, fibrinolysis and
inflammatory mediators. The study protocol and results
of these studies have been described previously [10,11].
During the study, treating physicians were asked to clas-
sify patients as having DF, DHF or DSS immediately after
patients were discharged. This intuitive classification was
based on knowledge of medical history, physical exami-
nation findings, clinical course and all available results of
routine tests (such as blood tests and chest X-ray). No
structured algorithm was used to classify patients. The
respective treating physicians were many different resi-
dents who worked under supervision of staff physicians at
the paediatric intensive care unit and the paediatric ward
of the Dr. Kariadi Hospital. Physicians were unaware of
the fact that a structured classification was performed after
completion of the study.
After completion of the study, two investigators (PK and
ATAM) determined the presence of the following four
clinical and laboratory manifestations on admission and
during follow up in every patient using the standard data
form: 1) fever or a history of acute fever, 2) haemorrhagic
manifestations (at least a positive tourniquet test), 3)
thrombocytopenia (platelet count ≤ 100.000 cells/mm3),BMC Infectious Diseases 2007, 7:22 http://www.biomedcentral.com/1471-2334/7/22
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and 4) signs of plasma leakage using laboratory findings
(haematocrit ≥ 20% above average for age, haematocrit ≥
20% compared to the haematocrit at hospital discharge,
hypoproteinemia or hypoalbuminemia) and chest X-ray
for the detection of pleural effusion. The presence of
ascites on physical examination was not used as a sign of
plasma leakage since routine physical examination has
definite limitations in the precise diagnosis of ascites [12].
The determination of the presence of these manifestations
was performed independently of each other and blind to
the treating physician's classification. Disagreement was
resolved by discussion and if necessary by adjudication of
a third reviewer (E.C.M.v.G.).
Patients were subsequently classified as having DHF using
these manifestations as proposed by the WHO [2]. If
patients did not have one or more of these manifestations,
they were considered to suffer from DF. In addition, sev-
eral modifications to the WHO classification system were
made as previously described [8]. Since all patients had
fever or had a history of acute fever, the remaining three
manifestations (haemorrhagic manifestations, thrombo-
cytopenia and signs of leakage) were used to make the
modifications. This resulted in six modified classification
systems (Table 1). DSS was diagnosed when all DHF cri-
teria were met plus evidence of circulatory failure defined
as hypotension for age (systolic pressure <90 mmHg for
those ≥ 5 years of age and <80 mmHg for those <5 years
of age) or narrow pulse pressure (<20 mmHg) [2].
Diagnostic procedures
Paired blood samples were tested for serologic evidence of
acute dengue infection. Commercially available enzyme-
linked immunosorbent assays (Focus Technologies,
Cypress, Calif., USA) were used for the detection of den-
gue virus specific IgG and IgM antibodies, according to the
procedures described by the manufacturer. The sensitivity
and specificity of these tests have been evaluated previ-
ously [13]. Cases were considered serologically-confirmed
if the IgM ELISA was positive during the acute phase of
disease (optical density of the sample higher than the
optical density of the cut off serum provided by the man-
ufacturer) and/or if a four-fold increase in IgG titre was
demonstrated in paired acute and convalescent sera. For
some patients, a definitive serodiagnosis was not possible
because no convalescent sample was obtained. Detection
of dengue virus antigen and/or viral RNA was attempted
in these cases using a dot blot immunoassay and a dengue
serotype specific reverse transcription PCR respectively
[14]. Patients with definitive serodiagnosis and/or posi-
tive dot blot and/or positive PCR were considered to have
confirmed dengue virus infection. The absence of dengue
virus antigen, viral RNA and negative serology, was indic-
ative of a non-dengue virus infection. When an alternative
clinical diagnosis was absent and serology was inconclu-
sive, patients were characterized as indeterminate.
Statistical analysis
The evaluation of the diagnostic accuracy of the various
classification systems was based on the presence of circu-
latory failure on admission and during follow up as the
"reference standard". We calculated the proportion of
patients with circulatory failure who were correctly classi-
fied as DHF (sensitivity). In addition, we calculated the
proportion of patients classified as DF by the WHO classi-
fication system and without circulatory failure who were
reclassified as having DHF when the modified classifica-
tion systems were applied. The corresponding exact 95%
confidence intervals (95% CI) were calculated from the
binomial distribution.
As a measure of agreement between various classifications
systems and the intuitive classification by the treating
physician, we calculated the weighted kappa (κw) statistic
with a 95% confidence interval. The κw values were inter-
preted as: poor agreement, ≤ 0.20; fair agreement, 0.21 to
0.40; moderate agreement, 0.41 to 0.60; good agreement,
0.61 to 0.80; or very good agreement, ≥ 0.81 [15]. A P-
value ≤ 0.05 was considered to indicate statistical signifi-
cance. Analyses were performed using SPSS 12.0.0. Agree-
ment between the various classification systems and
classification by treating physician was performed using
MedCalc version 8.0.0.0.
Role of funding source
The funding source had no involvement in the study
design, the collection, analysis, and interpretation of data,
in the writing of the report, and in the decision to submit
the paper for publication.
Table 1: Modified systems for the classification of dengue haemorrhagic fever.
Bleeding and thrombocytopenia
Bleeding and haemoconcentration
Haemoconcentration and thrombocytopenia
Bleeding and thrombocytopenia or haemoconcentration
Thrombocytopenia and haemoconcentration or bleeding
Haemoconcentration and bleeding or thrombocytopeniaBMC Infectious Diseases 2007, 7:22 http://www.biomedcentral.com/1471-2334/7/22
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Results
A total of 198 patients were initially enrolled in this study.
Parents from thirteen patients withdrew informed con-
sent during follow up. Two patients appeared not to suffer
from dengue during follow up (1 patient was diagnosed
with measles and 1 patient was diagnosed with malaria).
Of the remaining 183 patients, 28 patients (15%) had
inconclusive serology and were therefore categorised as
indeterminate. Three patients (2%) had definitive nega-
tive serology and were categorized as not dengue. The
presence of dengue was objectively confirmed in 152
patients (83%): 115 by serology, 21 by dot blot immu-
noassay and 16 by dengue serotype specific reverse tran-
scription PCR (seven Dengue virus serotype-1, four
Dengue virus serotype-2, four Dengue virus serotype-3
and one Dengue virus serotype 1). Of the patients with
confirmed dengue, 66 had evidence of circulatory failure:
52 (34%) had shock on admission (40 had hypotension,
2 had a narrow pulse pressure and 10 patients had both
hypotension and a narrow pulse pressure) and 14 (9%)
went on to develop shock within 48 hours after admis-
sion. Six patients (4%) died because of prolonged shock,
massive haemorrhage and respiratory failure. Patient
characteristics on admission are summarised in Table 2.
All patients were previously well and had an unremarka-
ble medical history.
Diagnostic accuracy of the various classification systems
According to the WHO classification system, 20 (13%)
patients were classified as having DF and 132 (87%) as
having DHF. Of the DHF group, 57 (43%) could be clas-
sified as having DSS. Of the 66 patients with confirmed
dengue and circulatory failure, 9 (14%) failed to meet all
four criteria necessary for a diagnosis of DHF, and were
thus classified as having DF. Six patients had a negative
tourniquet test result and no bleeding manifestations dur-
ing hospital admission, 1 patient never had a platelet
count less than 100.000 cells/mm3, and the remaining 2
had no evidence of haemoconcentration or other signs of
plasma leakage. The WHO classification system had a sen-
sitivity of 86% (95%CI 76–94). The number of patients
with circulatory failure classified as DHF changed when
the WHO classification system was modified. Interest-
ingly, all modifications had a higher sensitivity than the
WHO classification system. The sensitivities of the various
classification systems are shown in Table 3. Eleven
patients without circulatory failure were classified as hav-
ing DF according to the WHO classification system. Mod-
ification by the various systems came at the expense of
some DF patients being reclassified as DHF as shown in
Table 4.
Disease classification by treating physicians
Treating physicians classified 8 patients (5%) as having
DF and the remaining 144 patients (95%) as having DHF.
Of the 144 patients diagnosed as having DHF, 91 (63%)
were considered to have circulatory failure at admission or
at some point in time during admission in the hospital. In
addition to the 66 patients with hypotension or narrow
pulse pressure, treating physicians considered 25 patients
with tachycardia, restlessness and cold and clammy skin
as having compensated shock and subsequently diag-
nosed them as having circulatory failure. Agreements
between the various classification systems and disease
classification by treating physicians are shown in Table 5.
The WHO classification system and three modified classi-
fication systems showed moderate agreement with classi-
fication by the treating physician: bleeding +
thrombocytopenia,  κw value 0.53 (95% CI 0.41–0.64);
bleeding + thrombocytopenia or haemoconcentration, κw
value 0.55 (95% CI 0.43–0.66); WHO classification sys-
tem, κw value 0.57 (95% CI 0.45–0.68); and bleeding +
haemoconcentration, κw value 0.59 (95% CI 0.47–0.71).
The remaining three modified classification systems
showed good agreement with classification by the treating
physician: thrombocytopenia + bleeding or haemocon-
centration, κw value 0.64 (95% CI 0.53–0.74); thrombo-
cytopenia + haemoconcentration, κw value 0.67 (95% CI
0.56–0.78); and haemoconcentration + thrombocytope-
nia or bleeding, κw value 0.70 (95% CI 0.59–0.81).
Discussion
Our results show that a considerable number of dengue
virus infected patients with circulatory failure is not iden-
tified correctly when the WHO classification system is
applied. By modifying the combination of criteria that are
included in the WHO classification system, we were able
to identify more patients with circulatory failure. Overall,
86% of patients with circulatory failure were identified
correctly by the strict WHO classification system. By con-
trast, four modified classification systems recognized
more than 90% of patients with circulatory failure as
DHF.
These findings are largely in line with observations made
by Phuong and colleagues who studied a considerable
larger group of Vietnamese patients [8]. They also demon-
strated that all modified classification systems outper-
formed the WHO classification system in the
identification of 631 patients with confirmed dengue and
circulatory failure as a reference standard. A high sensitiv-
ity (> 90%) was found with the following modified classi-
fication systems: a haemorrhagic tendency with either
thrombocytopenia or haemoconcentration (93%),
haemoconcentration with either thrombocytopenia or a
haemorrhagic tendency (94%) and thrombocytopenia
with either haemoconcentration or a haemorrhagic ten-
dency (95%). This comes at the expense of more patients
being classified as DHF when any of the modified classifi-
cation systems is used compared to the WHO classifica-BMC Infectious Diseases 2007, 7:22 http://www.biomedcentral.com/1471-2334/7/22
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tion system. However, if the purpose of classifying dengue
disease severity is to identify the maximum number of
patients with circulatory failure, then it would seem, that
on the basis of Phuong's and our results, one of these
modified classification systems is to be preferred.
Likewise, we found that the WHO classification system
was in only modest agreement with the intuitive classifi-
cation by treating physicians. Treating physicians were
inclined to classify patients with evidence of plasma leak-
age as having DHF even in the absence of both thrombo-
cytopenia and a haemorrhagic tendency. As a result, the
modified classification systems haemoconcentration and
thrombocytopenia, and haemoconcentration with either
thrombocytopenia or a haemorrhagic tendency demon-
strated good agreement with the intuitive classification by
treating physicians. Phuong and colleagues noted that in
clinical practice many physicians use the modified system
of a haemorrhagic tendency usually together with throm-
bocytopenia rather than haemoconcentration. We
showed that this does not hold true for our study setting.
Treating physicians were inclined to classify severe cases as
suffering from DHF using a combination of haemocon-
centration with either thrombocytopenia or a haemor-
rhagic tendency instead of a haemorrhagic tendency
together with thrombocytopenia.
Although several modified classification systems were in
good agreement with the intuitive classification by treat-
ing physician, they still did not reach the magnitude of
Table 2: Baseline characteristics at admission of patients with confirmed acute dengue.*
Variable All patients (n = 152) Fatal cases (n = 6)
Age in years, median (IQR) 7 (5–10) 4 (4–6)
Male sex, n (%) 74 (49) 5 (83)
Duration of illness in days, median (IQR) 4 (3–4) 4 (4–5)
Haemorrhagic tendency, n (%) ¶ 133 (88) 6 (100)
Positive tourniquet test, n (%) 103 (68) 3 (50)
Spontaneous haemorrhage, n (%) £ 93 (61) 6 (100)
Hepatomegaly, n (%) 105 (69) 6 (100)
Systolic blood pressure in mmHg, median 
(IQR)
90 (80–100) 85 (68–93)
Hypotension for age, n (%) † 50 (33) 2 (33)
Pulse pressure <20 mmHg, n (%) 12 (8) 6 (100)
Pulse rate in beats/min, median (IQR) 120 (104–128) 130 (120–149)
Presence of pleural effusion, n (%) ‡ 102 (67) 5 (83)
Haematocrit in %, median (IQR) 41 (36–45) 42 (35–47)
Platelet count in cells/mm3, median (IQR) 58.000 (37.000–85.000) 31.000 (27.000–76.000)
Platelet count ≤ 100.000 cells/mm3, n (%) 131 (86) 5 (83)
* n, denotes number; IQR, denotes interquartile range
¶ haemorrhagic tendency was present when at least one of the following was present: a) positive tourniquet test, b) petechiae, ecchymoses or 
purpura, c) bleeding from the mucosa, gastrointestinal tract, injection sites or other locations, d) haematemesis or melena
£ spontaneous haemorrhage was defined as all haemorrhagic manifestations not caused by a tourniquet test or venapuncture
† hypotension is defined to be a systolic pressure of <80 mmHg for those <5 years of age, or <90 mmHg for those ≥ 5 years [2]
‡ the presence of pleural effusion was assessed through a chest X-ray
Table 3: Sensitivity of the various disease classification systems in 152 patients with confirmed acute dengue virus infection.*
Criteria used for the classification of DHF 
patients
Number of patients with circulatory failure (n = 
66) classified as DHF
Sensitivity (95% CI)
WHO classification system 57 86 (76–94)
Bleeding and thrombocytopenia 59 89 (79–96)
Bleeding and haemoconcentration 58 88 (78–95)
Haemoconcentration and Thrombocytopenia 63 96 (87–99)
Bleeding and thrombocytopenia or 
haemoconcentration
60 91 (81–97)
Thrombocytopenia and haemoconcentration 
or bleeding
65 99 (92–100)
Haemoconcentration and bleeding or 
thrombocytopenia
64 97 (89–100)
* n, denotes number; CI, denotes confidence interval; DF, denotes dengue fever; DHF, denotes dengue haemorrhagic fever; WHO, denotes World 
Health Organization.BMC Infectious Diseases 2007, 7:22 http://www.biomedcentral.com/1471-2334/7/22
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agreement we had expected (maximum κw value 0.70).
Two separate views of treating physicians played a promi-
nent part in this. First, a considerable number of patients
were classified as shock, although they did not meet the
WHO criteria for shock. Treating physicians classified
patients as having shock when symptoms and signs, such
as cool and clammy skin, rapid pulse, decreased urinary
output and confusion, indicating a stage I or compensated
shock were present. This was done even in the absence of
hypotension for age or a narrow pulse pressure. Second,
patients who had no evidence of plasma leakage but did
have a haemorrhagic tendency and thrombocytopenia
were classified as DF. However, when circulatory failure
was present a classification of DSS was given. To make a
distinction between patients with and without evidence of
plasma leakage an additional classification could be use-
ful [4,5].
Several potential limitations of this study should be
noted. First, grading of dengue disease severity was per-
formed at the time of discharge or after completion of the
study. By determining disease severity retrospectively, the
classification systems may only serve a limited number of
purposes. For example, they may be used to collect public
health data on incidence of severe disease in different
locations or over time. The classification systems are not
suited for the identification of those at risk for developing
severe disease, but they can be used as outcomes of inter-
est in clinical trials and observational studies focusing on
for example risk factors that may predict poor outcome.
Table 5: Agreement between the various classification systems and classification by the treating physician.*
Classification by treating physician
DSS DHF DF
WHO classification system DSS 57 0 0
DHF 23 52 0
DF 11 1 8
Bleeding and thrombocytopenia DSS 59 0 0
DHF 23 52 5
DF 9 1 3
Bleeding and haemoconcentration DSS 58 0 0
DHF 23 53 0
DF 10 0 8
Haemoconcentration and thrombocytopenia DSS 63 0 0
DHF 25 52 0
DF 3 1 8
Bleeding and thrombocytopenia or haemoconcentration DSS 60 0 0
DHF 23 53 5
DF 8 0 3
Thrombocytopenia and haemoconcentration or bleeding DSS 65 0 0
DHF 25 52 5
DF 1 1 3
Haemoconcentration and bleeding or thrombocytopenia DSS 64 0 0
DHF 25 53 0
DF 2 0 8
* DF, denotes dengue fever; DHF, denotes dengue haemorrhagic fever; DSS, denotes dengue shock syndrome; WHO, denotes World Health 
Organization.
Table 4: Proportion of patients without circulatory failure and classified as DF according to WHO criteria, that is reclassified to DHF 
when the various modified classification systems are applied.*
Criteria used for the classification of DHF patients Number of DF patients without circulatory failure reclassified to 
DHF
Proportion (95% CI)
Bleeding and thrombocytopenia 5 45 (17–77)
Bleeding and haemoconcentration 1 9 (0–41)
Haemoconcentration and Thrombocytopenia 2 18 (2–52)
Bleeding and thrombocytopenia or haemoconcentration 6 55 (23–83)
Thrombocytopenia and haemoconcentration or bleeding 7 64 (31–89)
Haemoconcentration and Bleeding or thrombocytopenia 3 27 (6–61)
* DF, denotes dengue fever; DHF, denotes dengue haemorrhagic fever; WHO, denotes World Health Organization.BMC Infectious Diseases 2007, 7:22 http://www.biomedcentral.com/1471-2334/7/22
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Second, patients' clinical course was assessed daily using
standard data forms, regular haematocrit and thrombo-
cyte measurements and additional diagnostic testing (i.e.
chest radiography). This enabled us to collect all the data
necessary for classification of disease severity. If regular
laboratory testing or additional diagnostic tests are not
performed because of for example limited resources, it
may be difficult to demonstrate the presence of haemo-
concentration with the possibility of misclassification. In
addition, one can elaborate on the use of ultrasound in
the detection of evidence of plasma leakage. We did not
perform an ultrasound scan of the chest and/or abdomen
because of practical issues. In several patients with circula-
tory failure, no evidence of plasma leakage was found
despite the use of a chest radiography and frequent meas-
urement of haematocrit (at admission, every 2 hours for
the first 6 hours and than every 6 hours until stable).
Whether ultrasound would have provided additional
cases with evidence of plasma leakage, is uncertain but
theoretically possible. Several studies reported on the use
of ultrasound in determining the presence of pleural effu-
sion, ascites or thickening of the gallbladder wall [16-19].
Although small amounts of abdominal and pericardial
effusions can be detected using ultrasonography, its supe-
riority over a combination of chest radiography and fre-
quent measurement of haematocrit has not been
demonstrated thus far. Finally, our analysis was confined
to Javanese patients. As far as we know, only one other
study performed in a Vietnamese population assessed the
same modifications [8]. We can therefore only speculate
on the possibility of extrapolating our findings to popula-
tions originating from other dengue affected areas like for
example the American region.
An increasing number of dengue infections have been
related to other unusual manifestations. These include
fulminant liver failure, cardiomyopathy, ocular manifes-
tations and neurological phenomena such as altered con-
sciousness, convulsions, and coma resulting from
encephalitis and encephalopathy [1,20-23]. Neurological
manifestations were initially ascribed to complications
secondary to DHF and DSS, although recently the inva-
sion of the central nervous system by dengue viruses has
been suggested [23]. Patients with symptoms or signs of a
suspected infection of the central nervous system were not
considered for inclusion in our study nor was additional
diagnostic testing (i.e. lumbar puncture) done in included
patients with minor neurological symptoms. We are
therefore unable to pronounce upon the possibility of an
increase in patients with encephalitis caused by dengue
viruses. If additional studies show that such is the case
than this would highlight the fact that the WHO classifi-
cation needs revision.
Conclusion
In conclusion, our results show that the WHO classifica-
tion system is less accurate in correctly classifying dengue
disease severity than all other modified classification sys-
tems. The implication of these findings is to question the
use of the strict WHO classification system to classify den-
gue disease severity, all the more because it lacks sufficient
agreement with how patients are classified in clinical prac-
tice. Additional research is needed in order to refine and
improve the clinical usefulness of the system.
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